相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines
Z. Adhim et al.
BRITISH JOURNAL OF CANCER (2011)
Protein Folding and the Order/Disorder Paradox
Prakash Kulkarni et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells
Shengbing Huang et al.
AUTOPHAGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells
Antonella Cusimano et al.
CELL CYCLE (2010)
Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward
David G. Menter et al.
CLINICAL CANCER RESEARCH (2010)
Effects of Short-term Celecoxib Treatment in Patients with Invasive Transitional Cell Carcinoma of the Urinary Bladder
Deepika Dhawan et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2
Szu-Ting Chen et al.
LEUKEMIA RESEARCH (2010)
Bladder Cancer Detection, Treatment and Outcomes: Opportunities and Challenges
David M. Latini et al.
UROLOGY (2010)
In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells
Jun Qin et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Endoplasmic reticulum stress and autophagy as targets for cancer therapy
Axel H. Schonthal
CANCER LETTERS (2009)
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib
Adel Kardosh et al.
CANCER RESEARCH (2008)
Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma
Simon J. Dovedi et al.
EUROPEAN UROLOGY (2008)
Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells
Jenilyn J. Virrey et al.
MOLECULAR CANCER RESEARCH (2008)
Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells
Deepika Dhawan et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Endoplasmic reticulum stress-induced cell death mediated by the proteasome
L. Egger et al.
CELL DEATH AND DIFFERENTIATION (2007)
GRP78 induction in cancer: Therapeutic and prognostic implications
Amy S. Lee
CANCER RESEARCH (2007)
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib
Peter Pyrko et al.
MOLECULAR CANCER THERAPEUTICS (2007)
(-)-epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78
Svetlana P. Ermakova et al.
CANCER RESEARCH (2006)
From acute ER stress to physiological roles of the Unfolded Protein Response
J Wu et al.
CELL DEATH AND DIFFERENTIATION (2006)
Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells
S Tsutsumi et al.
ONCOGENE (2006)
Cyclooxygenase inhibitors in urinary bladder cancer:: in vitro and in vivo effects
SI Mohammed et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Stress induction of GRP78/BiP and its role in cancer
JZ Li et al.
CURRENT MOLECULAR MEDICINE (2006)
3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells
SK Kulp et al.
CANCER RESEARCH (2004)
Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis
S Tsutsumi et al.
CELL DEATH AND DIFFERENTIATION (2004)
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide
TC Hour et al.
ANTI-CANCER DRUGS (2004)
Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells
XG Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A trip to the ER: coping with stress
DT Rutkowski et al.
TRENDS IN CELL BIOLOGY (2004)
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
AJ Dannenberg et al.
CANCER CELL (2003)
Clinical pharmacokinetics and pharmacodynamics of celecoxib - A selective cyclo-oxygenase-2 inhibitor
NM Davies et al.
CLINICAL PHARMACOKINETICS (2000)
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial
PT Leese et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
